For most people, appetite returns within weeks of stopping. Weight regain often follows within months.
That is not a willpower problem. It is a planning problem. This consultation exists to fix it.
This is a clinical review and planning consultation. It is not a prescription shortcut, not a guarantee of a particular outcome, and not a recommendation to stop medication. Sometimes continuing treatment is the right clinical decision.
Clinical appointments via CQC-registered Sutton Medical Consulting
Follow-up support from £125
Available in-person or by video consultation
The people who book this review are not looking for motivation. They already know what good looks like. What they do not have is a medically serious plan for what happens when the medication stops doing the work.
Most private GLP-1 clinics are set up to start treatment. Very few are set up to plan what comes after it. This one is.
GLP-1 drugs work by suppressing appetite, slowing gastric emptying, and reducing food noise. For most people, they work well. The problem is that none of those mechanisms persist after the medication stops.
When semaglutide was stopped in the STEP 4 trial, participants regained on average two thirds of their lost weight within 12 months. When tirzepatide was stopped in SURMOUNT-4, the pattern was similar.
This is not a failure of the medication. It is what happens when a pharmacological support is removed without anything in place to replace what it was doing. Appetite returns. Food noise returns. The old patterns return.
The question is not whether this will happen. The question is what is in place to manage it when it does.
"The question is not merely whether the medication worked. The question is what needs to be in place if the result is going to hold."
— Dr Dan Reardon · NHS A&E Doctor · GMC 6098984Not more information. A medically defensible plan for what happens next — specific to you, not a generic protocol.
Whether to taper, stop, continue, or move into a maintenance phase — with the clinical reasoning behind it.
What to track for appetite, weight, waist, symptoms, and relevant markers — and at what intervals.
A practical structure for food, movement, and recovery that works on normal weeks, not just perfect ones.
Clear signals that the plan is working — and clear signals that it is beginning to drift — before it becomes a problem.
What to do if hunger, weight, or old patterns begin to return — so you have a response before you need one.
A clear written summary to your GP where appropriate, keeping your care coordinated and documented.
"You have already invested in treatment. This is what protects that investment when the medication stops."
Book your Exit Strategy ReviewMost people who have spent 6–18 months on GLP-1 medication — typically £200–400 per month — have made a significant financial and personal investment in getting results. A single consultation gives you the plan. The Exit Plan gives you the support to execute it.
It is not a coaching programme. It is a structured clinical follow-up — designed to catch problems early, adjust the plan when needed, and give you a clinical contact point through the period when rebound risk is highest.
For patients who want structured clinical support through the transition and maintenance period — not just a plan, but a clinician alongside them while it matters most.
Book The Exit PlanSaves £70 vs individual appointments · Most popular choice
Most GLP-1 clinics are commercially tied to keeping patients on treatment. This service is not. The goal is the most clinically defensible next step for you — which may be continuation, reduction, or stopping.
Dr Dan Reardon is an NHS A&E doctor working in frontline emergency medicine alongside his private practice. That combination — clinical judgment under pressure, metabolic medicine, and a decade building evidence-based health systems — is what makes the plans different.
Not ideological. Not anti-medication. Clinically serious.
Also treating: SSRIs, PPIs, statins, and blood pressure medication · View all fees
Fees reflect more than appointment length. They include advance review of your history and results, clinical interpretation, and a clear written plan.
Full review, written plan, decision on next phase. The right starting point for most patients.
Progress review, results, plan refinement, and next-step decisions.
Smaller adjustments or review of agreed data points.
The Exit Plan (initial review + 2 follow-ups) is available as a structured package for £695. See above. · View all consultation fees →
Consultations available in-person at Sutton Coldfield or by video.
Investigation costs are separate. Where further testing is indicated, the review will identify exactly which tests are needed and the most appropriate route — NHS, GP referral, or private lab.
Not a prescription shortcut. A medical review, not a route to medication without clinical assessment.
Not a weight-loss programme. No targets, weigh-ins, or coaching calls.
Not motivational coaching. Clinical judgment, not lifestyle cheerleading.
Not anti-medication. Sometimes continuation is the right answer. The review arrives at the most defensible next step.
Book your GLP-1 Exit Strategy Review and leave with a written plan for what happens next.
Book your Exit Strategy Review — £395Clinical appointments via CQC-registered Sutton Medical Consulting · Sutton Coldfield · Video available